Use of the Enterprise™ Intracranial Stent for Revascularization of Large Vessel Occlusions in Acute Stroke by Kulcsár, Zsolt et al.
Use of the Enterprise™ Intracranial Stent for 
Revascularization of Large Vessel Occlusions in 
Acute Stroke
Zsolt Kulcsár1, 2, Christophe Bonvin3, Karl-Olof Lovblad4, Benjamin Gory1, Hasan Yilmaz1, 
Roman Sztajzel3, Daniel Rufenacht1, 2
Received: September 2, 2009; revision accepted: December 9, 2009
Published Online: February 28, 2010
Original ArticleNeuroradiology 
Clinical
 1 Neurointerventional Division, Geneva University Hospital, Switzerland,
2 Neurozentrum, Klinik Hirslanden, Zurich, Switzerland,
3 Neurology Division, Geneva University Hospital, Switzerland,
4 Neuroradiology Division, Geneva University Hospital, Switzerland.
Abstract  
Background and Purpose: Major cerebral thromboembolism often resists recanalization with currently available tech-
niques. The authors present their initial experience with a self-expanding stent for use in intracranial vascular reconstruc-
tion, permitting immediate recanalization of acute thromboembolic occlusions of the anterior circulation.
Patients and Methods: Patients treated with the Cordis Enterprise™ self-expanding intracranial stent system for acute 
thromboembolic occlusion of the major anterior cerebral arteries were included. Treatment comprised systemic and in-
traarterial thrombolysis, mechanical thrombectomy, and stent placement. Stent deployment, recanalization rate by means 
of Thrombolysis In Cerebral Infarction (TICI) scores and the clinical outcome were all assessed.
Results: Six patients presenting with acute carotid T (n = 2) or proximal middle cerebral artery occlusion (n = 4) were 
treated. The mean National Institutes of Health Stroke Scale (NIHSS) score at presentation was 14; the mean age was 
57 years. Successful stent deployment and immediate recanalization were achieved in all six with a TICI score of ≥ 2. 
Neither distal emboli nor any procedure-related complications were encountered. One patient developed symptomatic 
intracerebral hemorrhage and two patients needed decompressive craniectomy after treatment. The mean NIHSS score at 
10 days was 10, but only one patient showed a complete recovery at 3 months.
Conclusion: Intracranial placement of the Enterprise™ self-expanding stent has proven to be feasible and efficient in 
achieving immediate recanalization of occluded main cerebral arteries. The use of antiplatelet therapy after treatment 
may, however, increase the risk of reperfusion intracerebral hemorrhage.
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Einsatz des Enterprise-stent-systems zur Rekanalisierung großer intrakranieller Arterien beim 
akuten Schlaganfall
Zusammenfassung  
Hintergrund und Ziel: Die Wiedereröffnung großer thromboembolisch verschlossener Arterien gelingt mit bisherigen endo-
vaskulären Techniken häufig nicht. Die Autoren berichten über ihre Erfahrungen mit einem selbstexpandierenden Stentsystem 
zur Wiederherstellung des Blutflusses bei Patienten mit akutem thrombembolischem Verschluss in der vorderen Hirnzirkula-
tion.
Patienten und Methodik: Patienten mit Verschluss einer großen Arterie in der vorderen Gerhirnkreislauf, die mit einem 
Enterprise-Stentsystem (Cordis Enterprise™) behandelt wurden, wurde in diese Studie eingeschlossen. Die Behandlung 
beinhaltete darüber hinaus eine systemische und intraarterielle Lyse sowie eine mechanische Thrombektomie. Die Stent-
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Introduction
Thromboembolic occlusions of the major cerebral ar-
teries of the anterior circulation, the internal carotid ar-
tery (ICA) and the proximal middle cerebral artery 
(MCA), are conditions that almost always result in se-
vere neurologic compromise. Outcomes are usually 
poor, with a high mortality rate. Such lesions are often 
refractory to intravenous and/or intraarterial thrombol-
ysis [1–3]. Furthermore, early reocclusion after intrave-
nous thrombolysis is not infrequent, and is associated 
with clinical deterioration and poor outcome [4]. The 
impact of rapid recanalization on improvement of clini-
cal outcome is increasingly recognized [5, 6].
Additional therapeutic options for patients with 
major vessel occlusion include mechanical thrombecto-
my. However, for acute stroke patients failing pharma-
ceutical and mechanical thrombolysis, few alternatives 
remain. As a complementary treatment, with the advent 
of self-expanding stents suitable for intracranial deliv-
ery, stent application for rapid recanalization of acute 
intracranial vessel occlusions has resulted in high angio-
graphic success rates [7–12]. We present our initial ex-
perience with the off-label use of the Enterprise™ 
(Codman & Shurtleff, Inc., Raynham, MA, USA) intra-
cranial self-expanding stent for vascular reconstruction 
in acute stroke.
Patients and Methods
From the stroke database of our institution, we retro-
spectively identified and analyzed those patients, who, 
by suffering a major anterior circulation acute stroke, 
were treated with intracranial placement of the Enter-
prise™ stent, as an off-label use. Between November 
2007 and September 2008, altogether six such patients 
were treated. These patients were diagnosed by com-
puted tomography (CT) and CT angiography to have a 
major anterior circulation occlusion. Not responding to 
initial intravenous recombinant tissue plasminogen ac-
tivator (rtPA) or presenting in a time window excluding 
access to such treatment by policy of our local stroke 
center, we requested consent to intraarterial recanaliza-
tion procedures. After angiographic confirmation of 
persistent occlusion and failure or impossibility to pro-
ceed with mechanical thrombectomy, intracranial vas-
cular reconstruction was performed by stent placement 
with the Enterprise™ system (Figure 1).
Retrospectively, a database was created with the 
following characteristics: demographics (age, sex, car-
diovascular risk factors), clinical (etiology of stroke, 
time of symptom onset, baseline and 10-day National 
Institutes of Health Stroke Scale [NIHSS] scores, symp-
tom onset-to-treatment time, time to revascularization), 
radiographic and angiographic data (location and ex-
tension of clot, pharmacological treatment, and me-
chanical devices used before and after stenting). The 
degree of collateral flow was assessed according to the 
Angiographic Collateral Flow Grading System, where 
grade 0 means no collateral flow and grade 4 means 
complete and rapid collateral flow [13]. The degree of 
recanalization was classified based on the Thrombolysis 
In Cerebral Infarction (TICI) perfusion categories for 
reporting purposes [13]. Clinical outcome was assessed 
by modified Rankin Scale (mRS) at 3 months.
Procedural Technique
Under general anesthesia, a standard 7- or 8-F trans-
femoral approach was used to access the thrombosed 
vessel. Initial parenchymography [14] and selective 
study of the concerned carotid artery allowed for assess-
ment of the occlusion site, as well as of collateral supply. 
applikation, die Rekanalisierung unter Verwendung der TICI-Scores (Thrombolysis In Cerebral Infarctions) Scores und der 
klinische Verlauf wurden analysiert und bewertet.
Ergebnisse: Sechs Patienten wurden eingeschlossen. Zwei Patienten hatten einen Karotis-T-Verschluss und vier Patienten 
einen Verschluss der A. cerebri media. Der durchschnittliche NIHSS-Score (National Institutes of Health Stroke Scale) 
Scores betrug bei Aufnahme 14; das mittlere Alter lag bei 57 Jahren. Die Stentapplikation war bei allen Patienten erfolg-
reich, und eine Rekanalisierung mit einem TICI-Score ≥ 2 konnte in allen Fällen erzielt werden. Distale Emboli und proze-
durale Komplikationen traten nicht auf. Im Verlauf erlitt ein Patient eine symptomatische intrazerebrale Blutung, zwei 
weitere Patienten mussten zur Druckentlastung kraniektomiert werden. Der mittlere NIHSS-Score nach 10 Tagen betrug 10; 
nur ein Patient zeigte eine komplette Restitution nach 3 Monaten.
Schlussfolgerung: Die intrakranielle Applikation des Enterprise-Stentsystems (Cordis Enterprise™) zur Behandlung groß-
er arterieller Verschlüsse im vorderen Gehirnkreislauf ist möglich und sicher durchführbar. In dieser Serie zeigt sich eine 
hohe Effizienz mit Reperfusion bei allen Patienten. Die Gabe von Thrombozytenfunktionshemmern erhöht möglicherweise 
das Risiko einer großen Reperfusionsblutung.
Schlüsselwörter:  Akuter Schlaganfall · Intrakranieller Stent · Thrombolyse · Thrombektomie
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Mechanical thrombectomy attempts were made in three 
cases, having been combined with intraarterial throm-
bolysis in two patients. In the remaining three cases, due 
to a combination of anatomic considerations, advanced 
time and occlusion type, stent positioning was performed 
alone. The patients received peripro-
cedural heparin for systemic antico-
agulation with a bolus dose of 2,000–
5,000 IU followed by additional 1,000 
IU every 60 min. Immediately before 
or after stent deployment, intrave-
nous aspirin was administered (250 
or 500 mg) and intravenous tirofiban 
infusion was started adjusted to pa-
tients’ body weight.
For the performance of intracra-
nial stenting, a 0.014" microwire-
guided 0.021" inner diameter-sized 
Prowler® Select™ Plus microcatheter 
(Codman & Shurtleff, Inc.) was navi-
gated beyond the site of occlusion, 
followed by deploying a self-expand-
ing Enterprise™ stent. The length of 
the stent was chosen to completely 
cover the occluded vascular segment, 
and reached from 22 to 37 mm. The 
decision regarding the duration of 
treatment with tirofiban and an initi-
ation of clopidogrel was made based 
on the postprocedural brain CT find-
ings, and by taking the risks of hem-
orrhagic transformation into consid-
eration.
Results
Four female and two male patients with a mean age of 
57 ± 13 years presenting with severe acute stroke of the 
anterior circulation were treated with the Enterprise™ 
self-expanding stent system between November 2007 
and September 2008 at our stroke center. The mean 
Figures 1a to 1d. Unenhanced brain CT scan of patient #1 with hyperdense MCA sign (arrow; a). 
Parenchymography with contrast injection from the aortic arch demonstrating occlusion of 
the right ICA and MCA with a significant perfusion delay of the right hemisphere (b, c). Lateral 
view of right common carotid injection showing occlusion of the ICA (d).
a b
c d
Table 1. Characteristics of patients undergoing intracranial stenting. F: female; L: left; M: male; NIHSS: National Institutes of Health Stroke Scale; 
R: right; T: carotid T.
Patient # Age (years)/ Admission Stroke Time elapsed  Thrombus Grade of
 sex NIHSS score etiology Symptom onset  Angiography  location collateral
    to angiography  to stent deploy- (side) circulation
    (h:min) ment (min)
1 61/F 12 Atrial fibrillation 3:29 101 T + M1 (R) 3
2 48/F 16 Carotid dissection 4:48   51 M1 (L) 1
3 43/M 15 Cryptogenic 3:41   42 T + M1 (R) 1
4 49/F 16 Carotid dissection 4:13   35 T + M1 (L) 2
5 66/M 17 Cryptogenic 2:13 103 T + M1 (R) 1
6 76/F   9 Cardioembolic 2:47 120 M1 (L) 2
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baseline NIHSS score at presenta-
tion was 14 ± 3. After an initial CT, 
one patient was treated with intrave-
nous rtPA, receiving half of the 
body-weight-adjusted dose without 
clinical improvement. The mean 
time to first angiography was 3 h and 
31 min. The baseline demographic 
data, the clot location, and the grad-
ing of collateral circulation are listed 
in Table 1.
Unsuccessful mechanical throm-
bectomy was attempted in one case 
with the MERCI Retrieval System® 
(Concentric Medical Inc., Mountain 
View, CA, USA). The Penumbra 
System™ (PS; Penumbra Inc., Al-
ameda, CA, USA) was used prior to stenting in two 
cases. In one of these patients, partial recanalization of 
the M1 segment was achieved via thromboaspiration; 
however, the reperfusion catheter could not be intro-
duced in the occluded upper trunk of the MCA bifurca-
tion. The branch was then catheterized with the Prowl-
er® Plus microcatheter, and after unsuccessful local 
rtPA infusion, it could be recanalized by stent place-
ment. In the second case, no recanalization could be 
achieved with a combination of PS and intraarterial ly-
sis, so stent placement was used to reopen the occluded 
carotid bifurcation. In the other four cases, the perform-
ing physician decided upon immediate stenting. The oc-
cluded segment was recanalized in all cases by a self-ex-
panding Enterprise™ stent of 4.5 mm in diameter and 
22, 28 or 37 mm in length chosen depending on the 
length of the occlusion. In all cases, one stent allowed 
for covering the concerned vascular segments ranging 
from the MCA bifurcation to the supraclinoid or cav-
ernous carotid segment, or covering the M2 and M1 seg-
ments. The stent placement allowed for immediate re-
vascularization of the occluded segments. The mean 
time to stent deployment needed from the first angio-
graphic study was 75 ± 34 min, including diagnostic runs 
and mechanical maneuvers.
After stent deployment, immediate recanalization 
was observed in all six patients; however, the revascu-
larized vessels exhibited remaining luminal irregulari-
ties. This angiographic aspect was further improved 
upon administration of intravenous aspirin and tirofi-
ban. By the end of the procedure, two patients demon-
strated a recanalization grade of 2a, two of 2b, and two 
of 3 according to the TICI grading system (Figure 2). No 
procedure-related complications were encountered.
Brain CT scans 24–36 h post treatment demonstrat-
ed that three out of six patients developed an infarct af-
fecting more than two thirds of the MCA territory, and 
one patient developed a capsular, space-occupying in-
tracerebral hematoma. Two patients became candidates 
for decompressive craniectomy because of a space-oc-
cupying edema developed a few days after stroke onset, 
and one of them required repeated decompression be-
cause of a postoperative intracerebral hematoma that 
occurred 1.5 h after craniectomy. The mean NIHSS 
score at 10 days was 10 (range 0–17). Two patients ex-
hibited an improvement of > 2 points on the NIHSS. 
One patient showed a complete recovery with an mRS 
of 0, and two patients were dead at the 3-month fol-
low-up. One of them, although improved from an initial 
NIHSS score of 9 to 3 after thromboaspiration, died of a 
malignancy before the 3-month follow-up (Table 2). 
The stroke-related mortality was 16%.
Discussion
Current reported clinical experience reveals that occlu-
sions of the intracranial ICA and the M1 segment of the 
MCA are highly resistant not just to intravenous throm-
bolysis [15], but also to intraarterial pharmacological 
and mechanical recanalization efforts [16, 17]. It is well 
known, that carotid T and complete M1 segment occlu-
sions have the highest morbidity and mortality rates 
with less favorable clinical outcome [3, 18–20]. It has 
also been demonstrated that early recanalization is 
strongly related with better clinical outcome [5, 6, 16]. 
Figures 2a and 2b. Anterior (a) and lateral (b) view of the recanalized right ICA and MCA after 
stent deployment. Note the residual luminal irregularities still present after stent deployment 
(arrow) and the opacification of the lenticulostriate arteries (arrowhead).
a b
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The pooled analysis of the two MERCI trials has shown 
that best results were achieved with combined throm-
bectomy and thrombolytic maneuvers in patients with 
ICA occlusions, however, with recanalization rates lim-
ited to less than two thirds of patients [21]. Another me-
chanical thrombectomy device, the PS, has also shown 
promising results in terms of revascularization and clini-
cal outcome, with recanalization results ranging be-
tween 82% and 100% [22–24]. Despite the improving 
revascularization results, obviously not many options 
remain for the relatively high percentage of patients 
where the currently accepted mechanical and chemical 
thrombolytic attempts fail.
One solution for this group is recanalization using 
intracranial stents. After the advent of the intracranially 
trackable balloon-mounted stents and, later, the self-ex-
panding intracranial stents, attempts were made to use 
these devices in recanalization procedures of intracra-
nial arterial occlusions. There are few case reports and 
series demonstrating that these devices are effective in 
the recanalization of vascular occlusion with a relatively 
high angiographic success rate [7–12, 25–27]. In the mul-
ticenter cases series of Levy et al., who treated 18 such 
patients, the authors reported a 79% recanalization rate 
of TICI 2/3 [25]. In this case series, only three out of 
seven patients presenting with involvement of the ICA 
could be recanalized with stent placement, but vessel 
reconstruction to a TICI 2/3 degree could be achieved in 
all patients showing solitary M1 occlusions. Significant 
clinical improvement of > 4 points on the NIHSS was 
observed only in seven out of 14 patients, where a TICI 
2/3 grade recanalization could be achieved [25]. In a re-
cently published series comprising twelve acute stroke 
patients, the authors reported on the use of the Wing-
span™ stent for revascularization. In this series, five pa-
tients had an occlusion of the M1 or M2 segment of the 
MCA. Four of them had a partial recanalization of 
TIMI 2 or 3 degree, but only one patient showed a fa-
vorable outcome at 3 months [12]. These results demon-
strate that revascularization efforts with available intra-
cranial stents are not always successful. In a very recent 
multicenter study, the authors evaluated the use of the 
Enterprise™ stent as a salvage revascularization tool, 
after routine interventions aiming at recanalization had 
been unsuccessful. In this series, a TIMI 2/3 recanaliza-
tion rate of 100% was achieved with 75% of patients 
showing at least 4-point improvement on the NIHSS 
[28]. 
The Enterprise™ self-expanding vascular recon-
struction system was designed specifically for brain an-
eurysm repair. The stent has a closed-cell design with 
flared ends, which are both aspects we consider of ad-
vantage when it comes to trapping a clot toward the ves-
sel wall. Given its maximum available length of 37 mm, 
this device is long enough to cover extensive lesions 
without the need for multiple stent deployment. The 
stent was deployed in all of our cases starting from the 
MCA bifurcation to the supraclinoid or cavernous por-
tion of the ICA covering the whole occluded segment. 
The stent delivery Prowler® Select™ Plus microcatheter 
was easy and atraumatic to navigate in the cerebral vas-
culature and the stent was easy to deliver even in pa-
tients with tortuous precerebral and intracranial vessel 
anatomy. By its radial force, the stent was able to par-
tially reconstruct the occluded vessels immediately after 
deployment, and the residual luminal irregularities fur-
ther improved with the administration of aspirin and ti-
rofiban. The mean time to stent deployment and thus to 
recanalization was relatively short. The stent delivery 
and deployment did not produce any visible clot frag-
mentation, and there were no signs of late embolization 
in patients not suffering a major infarct. This was impos-
Table 2. Procedure and postprocedure data. mRS: modified Ranking Scale; NIHSS: National Institutes of Health Stroke Scale; PS: Penumbra™ Sys-
tem; rtPA: recombinant tissue plasminogen activator; TICI: Thrombolysis In Cerebral Infarction.
Patient # Treatment received TICI post procedure Craniectomy Clinical outcome
    10-day NIHSS score 3-month mRS score
1 MERCI 3 No   0 0
2 Intravenous rtPA 2a Yes 14 4
3 No 2b No 13 3
4 No 2a Yes 13 4
5 PS 2b No 17 6
6 PS 3 No   3 6
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sible to exclude in patients developing an infarct of more 
than two thirds of the MCA territory. In two cases, the 
stent caged the origin of an M2 branch, which remained 
occluded by clot at the immediate follow-up angiograms 
(patients with a TICI 2a recanalization). We suggest the 
immediate recanalization of the carotid artery and MCA 
in all of our patients to be attributable to the fact, that 
the stent was long enough to cover extended occlusions, 
and by its closed-cell design and radial force was able to 
compress and trap the thrombus.
There are, however, two major concerns using in-
tracranial stents for acute recanalization in ischemic 
stroke. One of them is the fear of side branch and perfo-
rator occlusion; opening the stent inside the thrombus 
might cause “snow-plowing” of the clot into side branch-
es or perforating arteries. In complete carotid and/or 
M1 segment occlusions, the arising branches covered by 
thrombus are already occluded, so if it were a case of 
pushing the thrombus further along these vessels, the 
situation would not get any worse. On the contrary, we 
believe that the anatomic vascular configuration forces 
the intracranial microdevices to track in close proximity 
to the vessel wall, i.e., along the outer curve (in the case 
of the carotid artery and the M1 segment, where the 
posterior communicating, the anterior choroidal and 
the lenticulostriate arteries arise). Based on this con-
cept, the microcatheter with the stent will be navigated 
between the vessel wall and the thrombus and not inside 
the clot itself. With deployment, the stent will push away 
the clot from the origin of the perforators and trap it 
against the opposite wall at the inner curve. We could 
indeed demonstrate the reappearance of the lenticulo-
striate arteries in all of our cases (see Figure 2a). The 
reperfusion of perforators was also demonstrated in a 
similar patient series [12].
The other concern is related to the need for anti-
platelet therapy after stent deployment, in view of the 
risk of intracerebral hemorrhage (ICH). On the one 
hand, the risk of combined antiplatelet therapy in acute 
stroke is not extensively studied and thus not recom-
mended by the current guidelines [29]. The risk of ICH 
may be further increased if tPAs were concomitantly 
used [29, 30]. However, stent deployment with antiag-
gregant therapy was occasionally used in combination 
with plasminogen activators in the above-mentioned 
case series [8–10]. On the other hand, the use of anti-
platelet therapy might constitute a problem in cases 
when patients require neurosurgical intervention such 
as decompressive craniectomy or hematoma evacua-
tion. In our case series, there was a relatively high inci-
dence of ICH after revascularization. One patient de-
veloped a space-occupying hematoma 15 h after stent 
implantation, which did not cause a worsening in his 
NIHSS score of 17. Another patient suffered a symp-
tomatic ICH 5 days after recanalization, soon after a 
decompressive craniectomy. Both patients were receiv-
ing oral aspirin and clopidogrel treatment.
Despite successful recanalization, there were only 
two patients showing an improvement of > 4 points on 
the NIHSS. The explanation for the relatively poor out-
come of our patient series may rely on the quality of 
collateral supply of the suffering brain. Although recan-
alized within a 6-h time window, all four patients with 
poor clinical outcomes had insufficient collateral circu-
lation of grade 1 or 2, according to the angiographic as-
sessment (Table 1).
A low patient number limits this study, as does its 
retrospective nature. It is hoped that a prospective study 
with a larger sample size might result in more clarity in 
order to determine the efficacy of self-expanding stents 
for acute intracranial vascular thrombosis.
Conclusion
In the setting of acute ischemic stroke caused by throm-
boembolic occlusion of the intracranial ICA or com-
plete M1 segment of the MCA, where chances of recan-
alization by the currently accepted methods are limited, 
intracranial vessel reconstruction by self-expanding 
stents seems to be feasible and angiographically effi-
cient. Our initial experience with the Enterprise™ 
self-expanding stent used for intracranial vascular re-
construction showed a high potential to reach immedi-
ate recanalization of acute major thromboembolic oc-
clusions. These results indicate that primary stenting 
might have a role in the treatment of acute strokes, 
where currently accepted modalities fail. The criteria 
for this kind of treatment should, however, be well de-
lineated to overcome the difficulties and possible com-
plications arising with the use of antiplatelet therapies 
in cases where huge infarction develops despite success-
ful recanalization. The collateral circulation through 
corticocortical anastomoses seems to have a crucial im-
portance in achieving better clinical outcomes after re-
vascularization.
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